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Abstract 
The elongases of very long-chain fatty acids (Elovl) account for the rate-limiting 
condensation step of the elongation process in fatty acid (FA) biosynthesis in vertebrates. One 
member of the Elovl family, Elovl4, has been regarded as a critical enzyme in vertebrates in 
the production of the so-called very long-chain fatty acids (VLC-FA), a group of compounds 
that have been scarcely explored in fish. Here we report on the cloning of a novel elovl4-like 
elongase from Atlantic salmon. The salmon elovl4 cDNA codes for a putative protein 
containing 306 amino acids. Heterologous expression in yeast demonstrated that salmon 
Elovl4 efficiently elongated saturated FAs up to 36:0, with 24:0 and 26:0 appearing as 
preferred substrates. Additionally, salmon Elovl4 effectively converted C20 and C22 
polyunsaturated fatty acids to elongated polyenoic products up to C36. Tissue distribution 
showed that elovl4 mRNA transcripts are abundant in eye, brain and testes, suggesting that, as 
described in mammals, these tissues are important metabolic sites for the biosynthesis of 
VLC-FA. Our results are discussed in comparison with the functional analyses observed in 
Elovl4 proteins from other vertebrates, and also other Elovl proteins investigated previously 
in Atlantic salmon. 
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1. Introduction 
    The very long-chain fatty acids (VLC-FA) are found in most animals and constitute a 
group of fatty acids (FA) with chain numbers normally ranging from C26 to C40 that 
can be saturated, monounsaturated or polyunsaturated (Rezanka, 1989; Poulos, 1995). 
In higher vertebrates, saturated VLC-FA have been found predominantly in tissues such 
as skin, hair and glands producing wax-like substances, whereas very long-chain 
polyunsaturated fatty acids (VLC-PUFA) accumulate in retina, brain, testis and 
spermatozoa (Rezanka and Sigler, 2009). Their relative low abundance compared to 
shorter chain FA (≤ C24) and the difficulty of their analysis has hindered investigation 
of the functions and metabolism of VLC-FA. Recent advances in analytical technology 
will enable more accurate characterisation of VLC-FA that will likely accelerate the 
understanding of the functions that these compounds play in living organisms (Agbaga 
et al., 2010b). 
    The biosynthesis of VLC-FA in mammals has been proposed to proceed through 
consecutive elongations of appropriate FA substrates catalysed by specific elongases of 
very long-chain fatty acids (Elovl) (Agbaga et al., 2008). Among them, Elovl4 has been 
demonstrated to be a critical enzyme in the biosynthesis of both saturated and 
polyunsaturated VLC-FA. Investigations on genetically-modified mice suggested a role 
for Elovl4 in the biosynthesis of saturated VLC-FA. Thus, mice lacking a functional 
ELOVL4 exhibited lower saturated VLC-FA (C > 24) in skin acyl-ceramides, which 
resulted in severe skin permeability disruptions in the pups that died perinatally 
(Cameron et al., 2007; Li et al., 2007; Vasireddy et al., 2007). Similarly, mutated 
Elovl4-knockin mice exhibited depleted levels of C32-C36 VLC-PUFA in retinal 
phosphatidylcholine (PC), indicating that mammalian ELOVL4 is also involved in the 
biosynthesis of VLC-PUFA (McMahon et al., 2007). The function of Elovl4 was later 
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confirmed by Agbaga et al. (2008) who demonstrated that the human ELOVL4 
efficiently elongated saturated VLC-FA up to C30, and VLC-PUFA from C28 to C38. 
Very recently, it was suggested that a further Elovl protein, Elovl2, may be involved in 
the production of n-6 VLC-PUFA that are critical in male fertility (Zadravec et al., 
2011).  
    Recently, we isolated and characterised elovl4 cDNAs from zebrafish Danio rerio 
(Monroig et al., 2010a) and cobia Rachycentron canadum (Monroig et al., 2011). These 
investigations have demonstrated that, similarly to mammals, teleostei Elovl4 are key 
enzymes in the biosynthesis of both saturated and polyunsaturated VLC-FAs up to C36. 
Expression patterns of fish elovl4 mRNA confirmed that retina, gonads and brain are 
the major metabolic sites for VLC-FA biosynthesis in teleosts. These findings 
highlighted the importance that the study of VLC-FA and their biosynthesis have in 
farmed fish in which fertility issues of broodstock, altered visual acuity, and disruptions 
of brain function can affect growth performance and the economics of farming. 
    Atlantic salmon, Salmo salar L., is an important species in the fish farming industries 
of Northern Europe, North America and Chile. It is also an interesting model to 
investigate FA metabolism as salmon present one of the most highly characterised and 
complete PUFA biosynthesis pathway, enabling higher replacement of fish oil with 
vegetable oil in aquafeeds without negative impacts on fish health or growth 
(Torstensen et al., 2008; Fjelldal et al., 2010). The search for a more sustainable 
candidate to replace fish oil is currently a major concern in aquaculture due to the 
dramatic depletion of wild fish stocks, which paradoxically are the source of traditional 
dietary lipid used in aquaculture. Therefore, it is important to understand the molecular 
mechanisms underlying the biosynthesis of PUFA and VLC-FA in salmon, and 
significant advances have been made in recent years with the molecular cloning and 
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functional characterisation of several genes encoding fatty acyl desaturases (Fad) 
(Hastings et al., 2005; Zheng et al., 2005; Monroig et al., 2010b), and elongases 
including Elovl5 and Elovl2 (Hastings et al., 2005; Morais et al., 2009).  
   The aim of the present study was to further characterise PUFA metabolism in Atlantic 
salmon, specifically focussing on an area previously unstudied in this important species, 
VLC-PUFA biosynthesis. Here we report the isolation and molecular cloning of an 
elovl4 cDNA, its functional analysis by heterologous expression in baker’s yeast, and its 
mRNA tissue distribution. Results are discussed in relationship with other Elovl 
proteins previously characterised in Atlantic salmon and other vertebrate species. 
 
2. Materials and Methods 
2.1.  Molecular cloning of salmon elovl4  
    The nucleotide sequences of zebrafish elovl4_b (gb|NM_199972.1|) and the Japanese 
medaka EST (gb|DK_113639.1|) were aligned and used to design the primers UNIE4F 
(forward) and UNIE4R (reverse) that enabled the amplification of a fragment of salmon 
elovl4 by PCR performed on eye cDNA (VersoTM cDNA kit, ABgene, Surrey, UK) 
(see Table 1 for primer details). PCR conditions consisted of a denaturing step at 95°C 
for 2 min, followed by 33 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 
30 s, and extension at 72°C for 45 s. The PCR product was sequenced (CEQ-8800 
Beckman Coulter Inc., Fullerton, USA) and the nucleotide sequence was blasted on 
GenBank confirming high similarity with other Elovl4 proteins. To obtain the full-
length cDNA sequence, specific PCR primers were designed (Table 1), and 3’ and 5’ 
rapid amplification of cDNA ends (RACE) PCR was performed on cDNA synthesised 
from eye total RNA following manufacturer’s instructions (FirstChoice® RLM-RACE 
kit, Ambion, Applied Biosystems, Warrington, UK). RACE PCR products were cloned 
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into pBluescript KS II vector (Stratagene, La Jolla, USA), sequenced and assembled 
using Bioedit (BioEdit version 5.0.6, Tom Hall, Department of Microbiology, North 
Carolina State University, USA) to determine the full-length cDNA sequence.  
 
2.2. Sequence and phylogenetic analysis of Elovl4 
    The amino acid (AA) sequence deduced from S. salar elovl4 cDNA was aligned with 
other orthologues including teleostei cobia R. canadum (gb|HM026361|) and zebrafish 
D. rerio Elovl4_a (gb|NP_957090.1|) and Elovl4_b (gb|NP_966266.1|), human 
ELOVL4 (gb|NP_073563.1|), and bird Gallus gallus predicted Elovl4 
(gb|XP_419868.2|) using ClustalW2. The AA sequences of salmon Elovl4 and other 
orthologues from mammals, birds and fish were also compared two by two using the 
EMBOSS Pairwise Alignment tool (http://www.ebi.ac.uk/Tools/emboss/align/). 
    A phylogenetic tree was constructed on the basis of the AA sequence similarities 
between the putative salmon Elovl4, vertebrate Elovl4-, Elovl2- and Elovl5-like 
proteins using the Neighbour Joining method (Saitou and Nei, 1987). The confidence in 
the resulting phylogenetic tree branch topology was measured by bootstrapping through 
1000 iterations. 
 
2.3. Functional characterisation in yeast 
    PCR fragments corresponding to the open reading frame (ORF) of the salmon 
putative elovl4 were amplified from eye cDNA using the high fidelity Pfu Turbo DNA 
polymerase (Stratagene, Agilent Technologies, Cheshire, UK). The isolation of the 
elovl4 ORF was achieved by performing a two-round PCR. The first PCR was 
performed with primers designed in the untranslated regions (UTRs), SALE4U5F and 
SALE4U3R (Table 1). PCR conditions consisted of an initial denaturating step at 95°C 
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for 1 min, followed by 32 cycles of denaturation at 95°C for 30 s, annealing at 58°C for 
30 s, extension at 72°C for 2 min, and a final extension at 72°C for 3 min. First round 
PCR products were used as template for the nested PCR with thermal conditions as 
described above, and with primers containing restriction sites (underlined in Table 1), 
SALE4VF (HindIII) and SALE4VR (XhoI). The DNA fragment containing the salmon 
elovl4 was digested with the corresponding restriction endonucleases (New England 
BioLabs, Herts, UK) and cloned into the yeast episomal plasmid pYES2 (Invitrogen, 
Paisley, UK). The resulting plasmid construct pYES2-elovl4 was transformed into 
Saccharomyces cerevisiae (strain INVSc1) using the S.C. EasyComp Transformation 
kit (Invitrogen). A single colony of transgenic yeast was grown in S. cerevisiae minimal 
medium-uracil supplemented with one of the following FA substrates: lignoceric acid 
(24:0), eicosapentaenoic acid (20:5n-3, EPA), arachidonic acid (20:4n-6, ARA), 
docosapentaenoic acid (22:5n-3, DPA), docosatetraenoic acid (22:4n-6, DTA) or 
docosahexaenoic acid (22:6n-3, DHA). DPA and DTA (>98-99% pure) were purchased 
from Cayman Chemical Co. (Ann Arbor, USA) and the remaining FA substrates (>99 
% pure) and chemicals used to prepare the S. cerevisiae minimal medium-uracil were 
from Sigma Chemical Co. Ltd. (Dorset, UK). Substrate FA final concentrations were as 
previously described (Monroig et al., 2010a). After 2 days, yeast were harvested and 
washed prior to lipid extraction and FA analyses. Yeast transformed with pYES2 
containing no insert were cultured under the same conditions described above and used 
as control treatment. 
 
2.4. FAME analysis by GC-MS 
    Yeast samples were homogenised in chloroform/methanol (2:1, v/v) containing 
0.01% BHT as antioxidant and total lipid extracted following the Folch method (Folch 
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et al., 1957). Fatty acid methyl esters (FAME) were subsequently prepared, extracted 
and purified (Christie, 2003). FAME were identified and quantified using a gas 
chromatograph (GC8000) coupled to a MD800 mass spectrometer (ThermoFisher 
Scientific, Hemel Hempstead, UK) as described previously (Monroig et al., 2010a). 
Elongation activities on PUFA substrates were calculated as the proportion of substrate 
FA converted to elongated FA product(s) [product area / (product area + substrate area)] 
x 100. Conversion rates from 24:0 were not calculated as yeast endogenously contains 
several of the FA involved in the elongation pathway and thus individual saturated FA 
(≥ C24) contents from elovl4-transformed yeast were compared to those of control yeast 
(Monroig et al., 2010a). 
 
2.5. Tissue distribution of salmon Elovl4 
    Tissue expression of elovl4 was measured by quantitative real-time PCR (qPCR). 
Total RNA was extracted from eye, brain, testes, liver, muscle, heart, gills, kidney, 
intestine and spleen from salmon parr (40 g, n = 3) maintained at the Institute of 
Aquaculture Freshwater Research Facility (Buckieburn, Scotland), using Tri Reagent 
(Sigma, Poole, UK). One µg of DNase (Ambion, UK) treated total RNA was reverse 
transcribed into cDNA using SuperScriptTM II Reverse Transcriptase (Invitrogen)  and 
primed with oligo dT (AB Applied Biosystems, California, USA). qPCR analyses were 
performed using a Quantica Machine (Techne, Cambridge, UK) in a final volume of 20 
µl containing 5 µl diluted (1/10) cDNA, 0.5 µM of each primer, and 10 µl of 
AbsoluteTM QPCR Sybr Green Mix 2x (ABgene, Epsom, UK). Amplifications were 
carried out with a systematic negative control (NTC, no template control) containing no 
cDNA. Thermal cycling was initiated at 95°C for 15 min, followed by 40 cycles with a 
denaturing step at 95°C for 15 s, annealing at 60°C (elovl4) or 61°C (elf-1α) for 15 s, 
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and extension at 72°C for 15 s. After the amplification cycle, a melting curve was 
performed with 0.5°C increments ranging between 75°C and 90°C to ensure the 
amplification of a single product. In addition, the qPCR product sizes were checked by 
agarose gel electrophoresis and the identity of random samples confirmed by 
sequencing. No primer-dimer formation occurred in the NTC. elf-1α was used as a 
reference gene for normalisation of gene expression. Primers used for qPCR analyses 
are shown in Table 1. 
 
2.6. Statistical analysis 
    Results were expressed as mean normalised ratios (± SE) between the copy numbers 
of the putative elovl4 transcripts and the copy numbers of the reference gene, elf-1α. 
Differences in the expression of elovl4 among tissues were analysed by one-way 
analysis of variance (ANOVA) followed by Tukey’s multiple comparison test at a 
significance level of P ≤ 0.05 (PASWS 18.0, SPSS Inc., Chicago, IL, USA).  
 
3. Results 
3.1. Salmon elongase Elovl4 sequence and phylogenetics 
    A 1,825 bp full-length cDNA sequence (5’UTR 231 bp, ORF 921 bp,  3’UTR 673) 
was obtained by 5’ and 3’ RACE PCR and deposited in the GenBank database under the 
accession number HM208347. The salmon elovl4 ORF encodes a putative protein of 
306 AA that shares 64.1-66.2% AA identity to mammalian orthologues including 
human, mouse and rat ELOVL4, and 62.6-63.3% identity with predicted Elovl4 
sequences from birds. Among fish Elovl4, phylogenetic analysis showed two clusters, 
one including Takifugu rubripes Elovl4 and Danio rerio Elovl4_a (70.2 and 73.8% AA 
identity to salmon Elovl4, respectively), and the other grouping the newly cloned 
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salmon Elovl4 together with D. rerio Elovl4_b (86.0% identity), Rachycentron 
canadum and Tetraodon nigroviridis (both presenting 83.4% identity with salmon 
Elovl4) (Fig.1). All fish Elovl4 elongases grouped together with the mammalian and 
bird orthologues, and more distantly from other members of the Elovl family such as 
Elovl2 and Elovl5 from fish and mammals. 
    The newly cloned Elovl4 contains the three typical features characteristic of Elovl 
proteins: a single HXXHH histidine box motif, five putative transmembrane-spanning 
domains containing hydrophobic AA stretches, and a carboxyl-terminal targeting signal 
believed to be responsible for the retrieval/retention of transmembrane protein to the 
endoplasmic reticulum (ER) (Fig. 2). The ER retrieval signal from salmon Elovl4 
possesses single lysine and arginine residues at the carboxyl terminus, RXKXX. In 
addition, the 17 AA residues that have been established to be highly conserved across 
22 member of the Elovl family were identified (Fig. 2).  
 
3.2. Functional characterisation 
    The salmon putative Elovl4 was functionally characterised by determining the FA 
profiles of transformed S. cerevisiae containing either the empty pYES2 vector (control) 
or the vector with the elovl4 ORF insert and grown in presence of potential FA 
substrates. To test the ability of salmon Elovl4 to biosynthesise saturated VLC-FA, 
transgenic yeast were grown in presence of lignoceric acid (24:0) (Table 2, Fig. 3). 
Control yeast transformed with empty vector contained measurable levels of the 
substrate 24:0 (7.1% of total saturates ≥ C24), 26:0, the major component among total 
saturates ≥ C24 representing 84.8%, and 28:0 (7.0% of total saturates ≥ C24). Further 
saturated VLC-FA up to C34 were also detected in small amount (Table 2). On the other 
hand, the pYES2-elovl4 transformed yeast showed a different profile of saturated FAs ≥ 
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C24 compared to the control yeast, with decreased contents of 24:0 and 26:0, and 
increased levels of 28:0 (3.5-fold), 30:0 (9.5-fold), 32:0 (3.0-fold) and 36:0, the latter 
being absent in control yeast. These results confirmed that salmon Elovl4 is involved in 
the biosynthesis of saturated VLC-FA. 
    The role of salmon Elovl4 in the biosynthesis of VLC-PUFA was investigated by 
culturing yeast transformed with the elovl4 ORF in the presence of one of either C20 
(20:5n-3 and 20:4n-6) or C22 (22:5n-3, 22:4n-6 and 22:6n-3) PUFA substrates. GC-MS 
analyses confirmed that control yeast did not have the ability to elongate LC-PUFA 
consistent with the previously reported lack of a PUFA elongase in S. saccharomyces 
strain INVSc1 (Agaba et al., 2005). However, pYES2-elovl4 yeast elongated PUFA, 
and VLC-PUFA with chain lengths up to C36 were produced (Table 3; Fig. 4). Elovl4 
showed higher activity towards 20:5n-3 and 20:4n-6 with up to 32.5% and 29.9% of 
each substrate converted to longer products, respectively, whereas C22 PUFA substrates 
were elongated to a lower extent (Table 3). It is noteworthy that salmon Elovl4 elongase 
was able to convert 20:5n-3 and 22:5n-3 to 24:5n-3, an intermediate substrate for DHA 
biosynthesis via the so-called Sprecher shunt pathway (Sprecher, 2000). In contrast, 
salmon Elovl4 had only very low activity towards DHA itself, whose conversion rate 
was only 5.4% (Table 3). This result was consistent with DHA not being a preferred 
substrate for elongation by Elovl4 (Suh and Clandinin, 2005). 
 
3.3. Tissue expression of elovl4 
    Tissue distribution of elovl4 mRNA transcript was measured by real-time qPCR. 
Results indicate that elovl4 was expressed in all tissues analysed, with the eye exhibiting 
significantly higher expression than any other (P<0.05) (Fig. 5). Although no significant 
differences were found in brain and testes they also showed high levels of transcripts, 
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with 4.9- and 3.8-fold increase, respectively, compared to liver expression signals. Liver 
exhibited the lowest expression levels, despite being regarded as a major metabolic site 
of LC-PUFA biosynthesis (Tocher, 2003).  
 
4. Discussion 
    Human ELOVL4 was discovered as a gene causing an inherited dominant form of 
Stargardt-like macular dystrophy (Bernstein et al., 2001; Zhang et al., 2001). Its AA 
sequence similarities with other Elovl proteins, together with its localisation in the ER 
(Grayson et al., 2005), the site of long-chain FA synthesis, suggested that Elovl4 had 
some functional role in FA biosynthesis. The first Elovl4 elongase that was functionally 
characterised, the human enzyme ELOVL4, confirmed a role in the biosynthesis of 
VLC-FA including both saturated and polyunsaturated (Agbaga et al., 2008). Despite 
the attention devoted to investigate the FA composition of fish and fish oil, the 
difficulties of analyses have meant that VLC-FA have been barely investigated in fish, 
with GC analysis routinely terminating with 22:6n-3 (DHA) or 24:1 (Ackman, 2000). 
However, VLC-FA longer than C24 are found in fish, as reported by Aveldaño (1988) 
who reported the presence of polyene VLC-FA up to C36 in retinal lipids of two fish 
species. In order to elucidate the molecular mechanisms of VLC-FA biosynthesis in 
fish, we have focussed on the isolation and characterisation of Elovl4 enzymes from a 
freshwater model species, zebrafish, the marine teleost cobia, and now the diadromous 
salmonid, Atlantic salmon.  
    The salmon Elovl4 possesses conserved regions, which coincide with predicted 
functional motifs that are common to all Elovl proteins. The histidine box, HXXHH, 
conserved in all elongases and also characteristic of desaturase and hydrolase enzymes 
containing a di-iron-oxo cluster (Fe-O-Fe), is involved in the coordination of electron 
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reception during reduction reactions occurring during FA elongation (Jakobsson et al., 
2006). By sequence comparison with vertebrate Elovl4 orthologues, five conserved 
putative transmembrane-spanning domains containing hydrophobic AA stretches can be 
predicted (Zhang et al., 2003). In addition the 17-AA motif described by Leonard et al. 
(2004) to be a common feature of elongases, was also identified in salmon Elovl4. The 
ER retrieval signal is essential for Elovl4 to integrate into the ER where its primary 
function occurs. Typically ELOVL4 proteins possess dilysine motifs (KKXX or 
KXKXX) at the C-terminus as observed in several mammals including human and 
mouse, as well as birds, and the zebrafish Elovl4_b (Zhang et al., 2003). The ER 
retrieval signal of salmon Elovl4 contains an arginine residue in position –5 from the C-
terminus of the protein, and conserves one lysine residue in the position –3 (RXKXX), 
the latter regarded as a critical residue for ER retrieval signal function (Jackson et al., 
1990). The RXKXX pattern is common to other teleostei Elovl4 including the puffer 
fish T. rubripes and T. nigroviridis, the D. rerio Elovl4_a, and cobia R. canadum 
(Zhang et al., 2003; Monroig et al., 2010a, 2011). 
    Elovl4 proteins are highly conserved through evolution (Leonard et al., 2004). 
Consistent with that, the phylogenetic analysis revealed that the salmon elovl4 cDNA 
encodes a protein more similar to other Elovl4 orthologues from mammals, birds and 
fish, than the other Elovl family proteins characterised previously in Atlantic salmon, 
the Elovl5_a and Elovl5_b, and Elovl2 (Hastings et al., 2005; Morais et al., 2009). 
Regarding fish Elovl4 proteins, two groups were identified with T. rubripes Elovl4 and 
D. rerio Elovl4_a grouping separately from D. rerio Elovl4_b, R. canadum, T. 
nigroviridis and Atlantic salmon Elovl4. This clustering pattern is consistent with the 
differing functional activities between the two fish Elovl4 groups. The two Elovl4 
present in zebrafish, Elovl4_a and Elovl4_b, were the first non-human Elovl4 proteins 
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functionally characterised (Monroig et al., 2010a), and they showed marked differences 
in their substrate specificity. Whereas zebrafish Elovl4_a was only able to produce 
saturated VLC-FA, the b isoform was efficient in the synthesis of both saturated VLC-
FA and VLC-PUFA up to C36. The other members of the same phylogenetic cluster, 
cobia (Monroig et al., 2011) and Atlantic salmon, have Elovl4 enzymes confirmed to 
have similar functions to those described for zebrafish Elovl4_b. Thus, yeast cells 
expressing the salmon elovl4 showed decreased percentages of 24:0 and 26:0, and 
concomitant increased levels of longer FA products. This indicates that fish Elovl4 have 
both 24:0 and 26:0 as preferred substrates. 
     In addition to a role in the biosynthesis of saturated VLC-FA, salmon Elovl4, as with 
zebrafish Elovl4_b (Monroig et al., 2010a) and cobia Elovl4 (Monroig et al., 2011), also 
appears to be a critical enzyme required for the biosynthesis of VLC-PUFA. Salmon 
Elovl4 showed high efficiency in the elongation of C20 and C22 PUFA substrates that 
led to the production of n-3 and n-6 polyenes containing up to C36. The VLC-PUFA are 
FA uniquely found in specific lipid molecules of retina (Alvedaño, 1987, 1988), brain 
(Robinson et al., 1990), and testis (Furland et al., 2003, 2007a,b; Zadravec et al., 2011). 
Although VLC-PUFA contents were not determined in salmon tissues in the present 
study, the tissue distribution analysis of elovl4 mRNA transcripts is consistent with eye 
(probably retina), brain and testis being prominent metabolic sites for the biosynthesis 
of VLC-PUFA in Atlantic salmon. Moreover, these results suggest that, of the Elovl 
proteins characterised in Atlantic salmon, only Elovl4 is able to produce PUFA products 
longer than C24. Previously, Elovl5 and Elovl2 elongases involved in LC-PUFA 
biosynthesis were functionally characterised with salmon Elovl5_a and Elovl5_b 
showing high elongation efficiency towards C18 and C20 PUFA, whereas Elovl2 
produced C24 PUFA from C20 and C22 PUFA and, in all cases, the production of 
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longer PUFA was negligible (Hastings et al., 2005; Morais et al., 2009). Interestingly, a 
recent study has shown that mice ELOVL2 participates in the biosynthesis of n-6 VLC-
PUFA that are critical in male fertility, and that 24:5n-6 appears a preferred substrate 
for murine ELOVL2 (Zadravec et al., 2011). Clearly, future investigations should 
elucidate the role that Elovl2 can play in the production of such potentially 
indispensable compounds in farmed fish. 
    Based on the functional analysis data obtained from yeast expression studies of 
several genes encoding both desaturases and elongases, we can now predict the LC- and 
VLC-PUFA biosynthetic pathway from the dietary essential fatty acids α-linolenic 
(18:3n-3) and linoleic (18:2n-6) in Atlantic salmon (Fig. 6). Together with the 
conversions previously described for the fatty acyl desaturases (Hastings et al, 2005; 
Zheng et al., 2005; Monroig et al., 2010b) and the Elovl2 and Elovl5 elongases 
(Hastings et al., 2005; Morais et al., 2009), the Elovl4 is now expanding the 
biosynthetic pathway. It is noteworthy that Atlantic salmon Elovl4, as Elovl2, may 
participate in the biosynthesis of DHA, as it is able to convert 22:5n-3 to 24:5n-3, which 
can be further	  Δ6-­‐desaturated to 24:6n-3 that subsequently is chain-shortened to DHA 
(Sprecher, 2000). These results further confirm that some teleostei Elovl4, in contrast to 
mammalian orthologues (Agbaga et al., 2010a), can play an active role in the 
biosynthesis of DHA (Monroig et al., 2010a; 2011). 
    In conclusion, the cDNA of an Elovl4 elongase of Atlantic salmon was cloned and 
characterised. The salmon Elovl4 possessed all the features of Elovl proteins and is 
phylogenetically closer to other Elovl4 orthologues of other animal classes than to other 
Elovl proteins of Atlantic salmon. The functional analysis demonstrated that Elovl4 is 
involved in the biosynthesis of both saturated VLC-FA and VLC-PUFA, similar to the 
pattern of activity described in some other Elovl4 elongases from fish species including 
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zebrafish (isoform Elovl4_b) and cobia. Our results also suggest that shorter (C20-C22) 
PUFA are suitable precursors for further elongation to VLC-PUFA by Elovl4. Further 
studies are investigating the impact that vegetable oil-based diets, devoid of potential 
Elovl4 C20-22 PUFA precursors, have on elovl4 transcriptional regulation and activity 
and on the biosynthesis and metabolism of VLC-PUFA in farmed fish. 
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FIGURE CAPTIONS 
Fig 1. Phylogenetic tree comparing the salmon Elovl4 with elongase proteins from other 
organisms. The tree was constructed using the Neighbor Joining method using MEGA4. 
The horizontal branch length is proportional to amino acid substitution rate per site. The 
numbers represent the frequencies (%) with which the tree topology presented was 
replicated after 1000 iterations.  
Fig 2. Comparison of the deduced amino acid (AA) sequence of the Atlantic salmon 
Elovl4 with those of zebrafish Danio rerio (isoforms Elovl4_a and Elovl4_b) and cobia 
Rachycentron canadum. The AA sequences were aligned using ClustalX, and 
identity/similarity shading was based on a 60% identity threshold. Identical residues are 
shaded black and similar residues are shaded grey. Indicated are the conserved HXXHH 
histidine box motif, five (I-V) putative membrane-spanning domains predicted by 
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Zhang et al. (2003), and the ER retrieval signal. An asterisk indicates each of the 17 AA 
residues conserved across Elovl proteins (Leonard et al., 2004).  
Fig 3. Role of Atlantic salmon Elovl4 elongase in the biosynthesis of saturated very 
long chain fatty acids (VLC-FA). Yeast transformed with pYES2 vector containing the 
elovl4 ORF (A) as insert were grown in the presence of α-lignoceric acid (24:0), and 
fatty acid composition determined. Saturated VLC-FA from control yeast transformed 
with empty pYES2 are shown in panel B. Substrate 24:0 (“*”) and its corresponding 
elongated products are indicated accordingly. Vertical axis, EI-MS response; horizontal 
axis, retention time. 
Fig 4. Role of Atlantic salmon Elovl4 elongase in the biosynthesis of very long chain 
polyunsaturated fatty acids (VLC-PUFA). Yeast transformed with pYES2 vector 
containing the ORF of elovl4 as insert were grown in the presence of PUFA substrates 
20:5n-3 (EPA), and 22:5n-3 (DPA), and fatty acid composition determined. Substrates 
(“*”) and their corresponding elongated products are indicated accordingly in the 
panels. Vertical axis, EI-MS response; horizontal axis, retention time. 
Fig 5. Tissue expression of elovl4 transcripts (mRNA) in Atlantic salmon. Absolute 
number of copies were quantified by qPCR and normalised by absolute levels of elf-1α. 
Results are means (±SE) of analysis performed in triplicate. * P<0.05 as determined by 
one-way ANOVA and Tukey's test. 
Fig 6. The biosynthesis pathway of long-chain and very long-chain polyunsaturated 
fatty acids from α-linolenic (18:3n-3) and linoleic (18:2n-6) acids. Enzymatic activities 
shown in the scheme are predicted from heterologous expression in S. cerevisiae of the 
∆5 fatty acyl desaturase (Fad), the three ∆6 Fad (Hastings et al., 2005, Zheng et al., 
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2005; Monroig et al., 2010b), and Elovl2 and Elovl5 elongases (Hastings et al., 2005; 
Morais et al., 2009). Steps catalysed by the newly characterised Atlantic salmon Elovl4 
are also shown. 
 
Table 1. Details of primer pairs (restriction sites for HindIII and XhoI underlined) used for the cloning of  
salmon elovl4 ORF in pYES2, and qPCR analysis of tissue expression. 
Aim	   Transcript	   Primer	   Primer	  sequence	   Amplicon	  size	   Ta	   Accession	  no.a	  
5’RACE	   elovl4	   SALE4R3	   5'-­‐CCACCAGAGGAATTTCTGGA-­‐3'	   763	  bp	   57°C	   HM208347	  	  
	   elovl4	   SALE4R2	   5'-­‐ACTTGATTCCGATCCACCAG-­‐3'	   875	  bp	   59°C	   HM208347	  	  
	   	   	   	   	   	   	  
3’RACE	   elovl4	   SALE4bF4	   5'-­‐GTTCTGCCCACAAGGTGG-­‐3'	   837	  bp	   58°C	   HM208347	  	  
	   elovl4	   SALE4bF5	   5'-­‐GCCCGTCACTAATGGTGTC-­‐3'	   815	  bp	   59°C	   HM208347	  	  
	   	   	   	   	   	   	  
ORF	  cloning	   elovl4	   UNIELO4F1	   5'-­‐GTCTACAACTTCAGCATGGTG-­‐3'	   439	  bp	   55°C	   HM208347	  	  
	   	   UNIELO4R2	   5'-­‐GGAACTGGATCATCTGAATAAT-­‐3'	   	   	   	  
	   elovl4	   SALE4U5F	   5'-­‐TCTCGAGAAGCATAAGCAGGA-­‐3'	   1,147	  bp	   58°C	   HM208347	  	  
	   	   SALE4U3R	   5'-­‐ATGCCAGGTACAATGCATTC-­‐3'	   	   	   	  
	   elovl4	   SALE4VF	   5'-­‐CCCAAGCTTAGGATGGAAGCTGTCACC-­‐3'	   942	  bp	   60°C	   HM208347	  	  
	   	   SALE4VR	   5'-­‐CCGCTCGAGTTACTCCCTTTTCGCTCTT-­‐3'	   	   	   	  
	   elovl4	   SAL45UF2	   5'-­‐TCCGCTTGCCTTCTGTAGTT-­‐3'	   1,653	  bp	   55°C	   HM208347	  	  
	   	   SAL43UR1	   5'-­‐CCCCTCAGTCCTATTGGTCA-­‐3'	   	   	   	  
	   	   	   	   	   	   	  
qPCR	   elovl4	   SAL4q3UF6 5'-TTGTCAAATTGGTCCTGTGC-3' 191	  bp	   61°C	   HM208347	  	  
	   	   SAL4q3UR6b 5'-TTAAAAGCCCTTTGGGATGA-3' 	   	   	  
	   elf-­‐1a	   qPCREloAF	   5’-­‐TCTGGAGACGCTGCTATTGTTG-­‐3’	   176	  bp	   59°C	   AF321836	  	  
	  	   	  	   qPCREloAR	   5’-­‐GACTTTGTGACCTTGCCGCTTGAG-­‐3’	   	  	   	  	   	  	  






Table 2. Functional characterisation of Atlantic salmon Elovl4 elongase and its role in 
biosynthesis of very long-chain saturated fatty acids (VLC-FA). Results are expressed 
as amount of each individual FA as a percentage of total peak area for all saturated 
VLC-FA (C ≥ 24). The yeast were transformed with either the empty pYES2 vector 
(control) or the pYES2 vector containing the salmon elovl4 ORF. 
FA	   Elovl4	   Control	  
	  	  	  	  24:0	  *	   3.6	   7.1	  
26:0	   65.5	   84.8	  
28:0	   24.6	   7.0	  
30:0	   4.8	   0.5	  
32:0	   0.6	   0.2	  
34:0	   0.1	   0.3	  
36:0	   0.8	   0.0	  






Table 3.	  Functional	  characterisation	  of	  Atlantic	  salmon	  Elovl4	  elongase	  and	  its	  role	  in	   the	   biosynthesis	   of	   very-­‐long-­‐chain	   polyunsaturated	   fatty	   acids	   (VLC-­‐PUFA)	  Data	  show	  the	  conversions	  of	  PUFA	  substrates	  and	  are	  expressed	  as	  percentage	  of	  fatty	   acid	   substrate	   converted	   to	   elongated	   product	   at	   each	   step	   of	   the	   pathway	  and	  overall	  (Total).	  
	  	   Conversion	  (%)	   	  	  
	  	  




	   20:5n-­‐3	   22:5n-­‐3	   15.4	   C20	  →	  22	   	  
	   	   24:5n-­‐3	   3.3	   C22	  →	  24	   	  
	   	   26:5n-­‐3	   0.6	   C24	  →	  26	   	  
	   	   28:5n-­‐3	   0.1	   C26	  →	  28	   	  
	   	   30:5n-­‐3	   1.4	   C28	  →	  30	   	  
	   	   32:5n-­‐3	   7.4	   C30	  →	  32	   	  
	   	   34:5n-­‐3	   4.0	   C32	  →	  34	   	  
	   	   36:5n-­‐3	   0.3	   C34	  →	  36	   	  
	  	   	  	   Total	   32.5	   	  	   	  	  
	   20:4n-­‐6	   22:4n-­‐6	   11.5	   C20	  →	  22	   	  
	   	   24:4n-­‐6	   3.1	   C22	  →	  24	   	  
	   	   26:4n-­‐6	   0.9	   C24	  →	  26	   	  
	   	   28:4n-­‐6	   0.6	   C26	  →	  28	   	  
	   	   30:4n-­‐6	   5.5	   C28	  →	  30	   	  
	   	   32:4n-­‐6	   7.2	   C30	  →	  32	   	  
	   	   34:4n-­‐6	   1.1	   C32	  →	  34	   	  
	   	   36:4n-­‐6	   0.1	   C34	  →	  36	   	  
	  	   	  	   Total	   29.9	   	  	   	  	  
	   22:5n-­‐3	   24:5n-­‐3	   5.7	   C22	  →	  24	   	  
	   	   26:5n-­‐3	   0.7	   C24	  →	  26	   	  
	   	   28:5n-­‐3	   0.2	   C26	  →	  28	   	  
	   	   30:5n-­‐3	   1.9	   C28	  →	  30	   	  
	   	   32:5n-­‐3	   9.8	   C30	  →	  32	   	  
	   	   34:5n-­‐3	   3.6	   C32	  →	  34	   	  
	   	   36:5n-­‐3	   0.1	   C34	  →	  36	   	  
	  	   	  	   Total	   22.1	   	  	   	  	  
	   22:4n-­‐6	   24:4n-­‐6	   4.3	   C22	  →	  24	   	  
	   	   26:4n-­‐6	   1.2	   C24	  →	  26	   	  
	   	   28:4n-­‐6	   0.8	   C26	  →	  28	   	  
	   	   30:4n-­‐6	   8.2	   C28	  →	  30	   	  
	   	   32:4n-­‐6	   11.1	   C30	  →	  32	   	  
	   	   34:4n-­‐6	   1.5	   C32	  →	  34	   	  
	   	   36:4n-­‐6	   0.1	   C34	  →	  36	   	  
	  	   	  	   Total	   27.1	   	  	   	  	  
	   22:6n-­‐3	   24:6n-­‐3	   3.2	   C22	  →	  24	   	  
	   	   26:6n-­‐3	   0.3	   C24	  →	  26	   	  
	   	   28:6n-­‐3	   0.0	   C26	  →	  28	   	  
	   	   30:6n-­‐3	   0.1	   C28	  →	  30	   	  
	   	   32:6n-­‐3	   1.3	   C30	  →	  32	   	  
	   	   34:6n-­‐3	   0.4	   C32	  →	  34	   	  
	   	   36:6n-­‐3	   0.0	   C34	  →	  36	   	  





















0.1 Mus musculus ELOVL4 (NM_148941) 
Rattus norvegicus ELOVL4 (XM_001062735) 
Homo sapiens ELOVL4 (NM_022726) 
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D. rerio Elovl4b (NM_199972) 
Salmo salar Elovl4 (HM208347)  
Rachycentron canadum Elovl4 (HM026361) 
Tetraodon nigroviridis Elovl4 (CAAE01014660) 
D. rerio Elovl2 (NM_001040362) 
S. salar Elovl2 (FJ237532) 
H. sapiens ELOVL2 (NM_017770) 
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 L
o
g
 n
o
rm
a
liz
e
d
 v
a
lu
e
 /
 1
0 
8 
20:4n‐3 
20:5n‐3 
22:5n‐3 
18:4n‐3 
18:3n‐3 
Δ6 Fad 
26:5n‐3 
36:5n‐3 
34:5n‐3 
32:5n‐3 
30:5n‐3 
28:5n‐3 
24:5n‐3 
22:6n‐3 
24:6n‐3 
β oxida'on 
20:3n‐6 
20:4n‐6 
22:4n‐6 
18:3n‐6 
18:2n‐6 
Δ6 Fad 
26:4n‐6 
36:4n‐6 
34:4n‐6 
32:4n‐6 
30:4n‐6 
28:4n‐6 
24:4n‐6 
22:5n‐6 
24:5n‐6 
β oxida'on 
Elovl4, Elovl5 
Δ6 Fad 
Elovl2, Elovl4 
Δ5 Fad 
Elovl2, Elovl4, Elovl5 
Elovl4 
